Free Trial

Organigram Global (OGI) Competitors

Organigram Global logo
$1.53 +0.02 (+1.32%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$1.53 0.00 (-0.07%)
As of 07/25/2025 07:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OGI vs. ACB, CRON, SNDL, TLRY, VFF, KALV, OCS, ANAB, AVBP, and VIR

Should you be buying Organigram Global stock or one of its competitors? The main competitors of Organigram Global include Aurora Cannabis (ACB), Cronos Group (CRON), SNDL (SNDL), Tilray Brands (TLRY), Village Farms International (VFF), KalVista Pharmaceuticals (KALV), Oculis (OCS), AnaptysBio (ANAB), ArriVent BioPharma (AVBP), and Vir Biotechnology (VIR).

Organigram Global vs. Its Competitors

Organigram Global (NASDAQ:OGI) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings, media sentiment and analyst recommendations.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Organigram Global
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Aurora Cannabis
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
3.67

In the previous week, Aurora Cannabis had 2 more articles in the media than Organigram Global. MarketBeat recorded 3 mentions for Aurora Cannabis and 1 mentions for Organigram Global. Organigram Global's average media sentiment score of 1.87 beat Aurora Cannabis' score of 0.53 indicating that Organigram Global is being referred to more favorably in the media.

Company Overall Sentiment
Organigram Global Very Positive
Aurora Cannabis Positive

34.6% of Organigram Global shares are held by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are held by institutional investors. 0.1% of Organigram Global shares are held by insiders. Comparatively, 0.0% of Aurora Cannabis shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Aurora Cannabis has higher revenue and earnings than Organigram Global. Organigram Global is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Organigram Global$117.47M1.74-$33.39M$0.1015.30
Aurora Cannabis$246.72M1.10$1.63M$0.1144.00

Organigram Global has a beta of 1.36, suggesting that its share price is 36% more volatile than the S&P 500. Comparatively, Aurora Cannabis has a beta of 1.75, suggesting that its share price is 75% more volatile than the S&P 500.

Organigram Global has a net margin of 8.05% compared to Aurora Cannabis' net margin of 1.32%. Aurora Cannabis' return on equity of 0.13% beat Organigram Global's return on equity.

Company Net Margins Return on Equity Return on Assets
Organigram Global8.05% -5.93% -4.39%
Aurora Cannabis 1.32%0.13%0.10%

Summary

Aurora Cannabis beats Organigram Global on 12 of the 16 factors compared between the two stocks.

Get Organigram Global News Delivered to You Automatically

Sign up to receive the latest news and ratings for OGI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OGI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OGI vs. The Competition

MetricOrganigram GlobalMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$202.25M$10.55B$5.69B$9.50B
Dividend YieldN/A2.00%4.58%4.01%
P/E Ratio15.3017.0728.1020.05
Price / Sales1.7429.17432.4890.19
Price / CashN/A23.0336.2258.56
Price / Book0.743.698.665.87
Net Income-$33.39M$234.77M$3.25B$258.55M
7 Day Performance5.52%6.32%4.22%3.73%
1 Month Performance9.29%7.94%10.51%11.75%
1 Year Performance-6.13%-13.57%34.40%18.03%

Organigram Global Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OGI
Organigram Global
1.3229 of 5 stars
$1.53
+1.3%
N/A-5.6%$202.25M$117.47M15.30860Positive News
ACB
Aurora Cannabis
0.2807 of 5 stars
$4.70
+3.8%
N/A-16.4%$254.80M$246.72M42.731,130
CRON
Cronos Group
1.9825 of 5 stars
$2.09
+4.0%
N/A-15.3%$775.22M$117.61M16.08450News Coverage
SNDL
SNDL
1.7229 of 5 stars
$1.58
+2.6%
$4.00
+153.2%
-28.9%$404.67M$671.81M-5.452,516News Coverage
Upcoming Earnings
TLRY
Tilray Brands
1.8077 of 5 stars
$0.67
+8.4%
$1.92
+184.6%
-61.3%$625.34M$788.94M-0.642,650Upcoming Earnings
Options Volume
VFF
Village Farms International
1.3085 of 5 stars
$1.38
+3.8%
N/A+31.0%$149.41M$336.18M-3.831,400Analyst Upgrade
KALV
KalVista Pharmaceuticals
3.9681 of 5 stars
$15.56
+1.1%
$26.29
+68.9%
+1.3%$768.79MN/A-4.22100
OCS
Oculis
2.2573 of 5 stars
$17.50
flat
$35.33
+101.9%
+54.7%$764.09M$780K-6.632
ANAB
AnaptysBio
1.9086 of 5 stars
$26.17
+1.0%
$42.38
+61.9%
-27.6%$761.54M$91.28M-5.40100News Coverage
Positive News
Analyst Forecast
AVBP
ArriVent BioPharma
2.1606 of 5 stars
$21.55
-2.3%
$39.29
+82.3%
+0.2%$754.39MN/A-5.7240Positive News
Analyst Forecast
Analyst Revision
VIR
Vir Biotechnology
3.5989 of 5 stars
$5.52
+2.0%
$30.25
+448.0%
-47.0%$747.87M$74.21M-1.31580News Coverage

Related Companies and Tools


This page (NASDAQ:OGI) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners